Publication at Second Faculty of Medicine |
2011
Abstract
Invasive fungal infection (IFI) continues to be frequent cause of morbidity and mortality in neonates and in both immunocompromised and immunocompetent children. Although these infections have been well characterized in adults, incidence, diagnostic tools, analysis of risk factors and treatment outcomes have not been well described in children.
Data regarding the efficacy, safety and proper dosing of widely used antifungals in children of different age categories still remain to be solved. In this paper we would like to summarize news published about this specific topic of pediatrics over year 2010 and excerpted in PubMed database.